Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL388090 | 0.85 | — | — | |
| SCHEMBL3541864 | 0.79 | TSHR (0.44) | TSHR | |
| SCHEMBL10932800 | 0.79 | TSHR (0.67) | TSHR | |
| SCHEMBL221838 | 0.76 | — | — | |
| SCHEMBL26317085 | 0.75 | TSHR (0.50) | TSHR | |
| SCHEMBL2539746 | 0.75 | — | — | |
| SCHEMBL10526330 | 0.75 | TSHR (0.50) | TSHR | |
| SCHEMBL2536202 | 0.73 | — | — | |
| SCHEMBL20903955 | 0.73 | ACE2 (0.47) | TSHR | |
| SCHEMBL2537735 | 0.71 | TSHR (0.46) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8344142-B2 | perylenetetracarboxylic diimide core having side chains (groups or mesogens) attached to the core; to provide charge-transport materials having various volatilities, solubilities, crystallinity, and charge transport ability; organic light emitting diode; photovoltaic cells, light-emitting diodes | GEORGIA TECH RESEARCH CORPORATION (US) | 2013-01-01 | — | — | US | claimed |
| US-8039625-B2 | Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-10-18 | — | — | US | claimed |
| US-20090044863-A1 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | NATIONAL SCIENCE FOUNDATION | 2009-02-19 | — | — | US | claimed |
| US-20080223444-A1 | Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | GEORGIA TECH RESEARCH CORPORATION | 2008-09-18 | — | — | US | claimed |
| WO-2005124453-A2 | PERYLENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2005-12-29 | — | — | WO | claimed |
| CN-113330096-B | Use of substituted or unsubstituted polycyclic aromatic compounds for high resolution microscopy | 马克斯·普朗克索赔科学公司 | 2024-05-31 | — | — | CN | disclosed |
| US-11958796-B2 | Hydrophilic and particularly water soluble DBOV-derivatives | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2024-04-16 | — | — | US | disclosed |
| CN-112839922-B | Hydrophilic and in particular water-soluble DBOV derivatives | 马克斯·普朗克索赔科学公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-3183250-B1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | CLAP CO LTD (KR) | 2023-10-04 | — | — | EP | disclosed |
| EP-3830217-B1 | USE OF A SUBSTITUTED OR UNSUBSTITUTED POLYCYCLIC AROMATIC HYDROCARBON COMPOUND FOR HIGH-RESOLUTION MICROSCOPY | MAX PLANCK GESELLSCHAFT (DE) | 2022-07-20 | — | — | EP | disclosed |
| EP-3183757-B1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM | CLAP CO LTD (KR) | 2022-05-04 | — | — | EP | disclosed |
| US-20220009870-A1 | HYDROPHILIC AND PARTICULARLY WATER SOLUBLE DBOV-DERIVATIVES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-01-13 | — | — | US | disclosed |
| EP-0804507-A1 | SUBSTITUTED QUATERRYLENE TETRACARBOXYLIC ACID DIIMIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-11-05 | — | — | EP | disclosed |
| WO-1997022608-A1 | 1,7-DISUBSTITUTED PERYLENE-3,4,9,10-TETRACARBOXYLIC ACIDS AND DIANHYDRIDES AND DIIMIDES OF SAID ACIDS | BASF AKTIENGESELLSCHAFT (DE) | 1997-06-26 | — | — | WO | disclosed |
| WO-1997022607-A1 | 1,7-DIAROXY- OR 1,7-DIARYLTHIO-SUBSTITUTED PERYLENE-3,4,9,10-TETRACARBOXYLIC ACIDS AND THEIR DIANHYDRIDES AND DIIMIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-06-26 | — | — | WO | disclosed |
| WO-1996022331-A1 | PROCESS FOR PRODUCING AND PURIFYING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-07-25 | — | — | WO | disclosed |
| WO-1996022332-A1 | SUBSTITUTED QUATERRYLENE TETRACARBOXYLIC ACID DIIMIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-07-25 | — | — | WO | disclosed |
| EP-0442360-B1 | Process for transfer of azo dyes | BASF AG (DE) | 1995-11-22 | — | — | EP | disclosed |
| US-5145828-A | To a plastic-coated paper by diffusion by means of energy source | BASF AKTIENGESELLSCHAFT (DE) | 1992-09-08 | — | — | US | disclosed |
| EP-0442360-A1 | Process for transfer of azo dyes | BASF Aktiengesellschaft (DE) | 1991-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220009870-A1 | HYDROPHILIC AND PARTICULARLY WATER SOLUBLE DBOV-DERIVATIVES | NR1H4, HDGF, ABHD16A | TSHR 1679/4885 |
| US-11958796-B2 | Hydrophilic and particularly water soluble DBOV-derivatives | NR1H4, HDGF, ABHD16A | TSHR 1679/4885 |
| US-20080223444-A1 | Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | SLC43A1, SLC3A2, SLC16A3 | TSHR 4842/4885 |
| US-20090044863-A1 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | SLC18A3, CORO1C, SLC18A1 | TSHR 4833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.